EU Orders 50 Million More Covid-19 Vaccine Doses From Pfizer-BioNTech
April 14 2021 - 8:40AM
Dow Jones News
By Daniel Michaels
The European Union, grappling with the potential loss of
vaccines from Johnson & Johnson, will buy an additional 50
million doses of the Covid-19 shot from BioNTech and Pfizer Inc.
for the current quarter and is in talks for up to 1.8 billion more
doses over the next two years.
European Commission President Ursula von der Leyen said the new
order will bring total deliveries of the Pfizer-BioNTech vaccine in
the quarter from March through June to 250 million doses. The EU
also expects 35 million doses from Moderna Inc. and 70 million
doses from AstraZeneca PLC during the quarter.
J&J had been expected to deliver 55 million doses during the
quarter, but that is now in question after the company suspended
shipments this week due to concerns about possible links to rare
blood clots.
J&J's vaccine requires only one shot, compared to two shots
for all the others, so its deliveries had represented an even
larger proportion of total effective vaccinations. Prior to
Wednesday's announcement of new Pfizer-BioNTech deliveries, the
J&J shots had accounted for between 15% and 25% of
current-quarter vaccinations.
Write to Daniel Michaels at dan.michaels@wsj.com
(END) Dow Jones Newswires
April 14, 2021 08:25 ET (12:25 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Sep 2023 to Sep 2024